Sweet's syndrome after granulocyte colony-stimulating factor administration for refractory myelodysplastic syndrome
The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management
Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory
Guidelines for the clinical use of red cell transfusions
A DNA-based immunization protocol to produce monoclonal antibodies to blood group antigens
Residual risk of transfusion in Ghana
Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia
Molecular characterization of the PK-LR gene in sixteen pyruvate kinase-deficient patients
Erythropoietin synthesis by tumour tissues in a patient with uterine myoma and erythrocytosis
Decreased expression of transcription factor GATA-2 in haematopoietic stem cells in patients with aplastic anaemia
The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation
Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb–IIIa inhibitors than by peptide and peptidomimetic inhibitors
Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mechanism
Haemophilia B mutations in Sweden: a population-based study of mutational heterogeneity
Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease
Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever
Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease
Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol
Drug monitoring of low-dose PEG-asparaginase (OncasparTM) in children with relapsed acute lymphoblastic leukaemia
Cytogenetic risk groups in acute myeloblastic leukaemia differ greatly in their semi-solid colony growth
The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI
Phenotypic and functional characterization of the host immune compartment of chronic myeloid leukaemia patients in complete haematological remission
Molecular characterization of a myelodysplasia-associated chromosome 7 inversion
Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies
Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease
Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma
Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies
Treatment of refractory T-cell malignancies using gemcitabine
Human herpesvirus 8 DNA sequences are present in bone marrow from HIV-negative patients with lymphoproliferative disorders and from healthy donors
High-grade lymphoma mimicking bone crisis in Gaucher's disease
Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation
Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma
Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres
Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis
Changes in the pattern of TCR Vβ repertoire expression after bone marrow transplant is linked to the HLA haplotype in humans
Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells
Decreased yield, phenotypic expression and function of immature monocyte-derived dendritic cells in cord blood
Association between the SDF1- 3′A allele and high levels of CD34+ progenitor cells mobilized into peripheral blood in humans
Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a single-centre experience
Tel/aml1 fusion is not a prognostic factor in dutch childhood acute lymphoblastic leukaemia
Will the high rates of post-treatment sexual stage parasitaemia seen in malaria-endemic areas make the optiMAL antigen test unreliable in predicting malaria treatment outcome?
Reply to Tjitra and Anstey
Central nervous system relapse in a patient with acute promyelocytic leukaemia treated with arsenic tri-oxide